The N terminal domain (NTD) of Nucleocapsid protein (N protein) of coronavirus (CoV)
binds to the viral (+) sense RNA and results in CoV ribonucleoprotien (CoV RNP) complex, …

Ferritin is a known inflammatory biomarker in COVID-19. However, many factors and co-morbidities
can confound the level of serum ferritin. This current metaanalysis evaluates serum …

Galantamine hydrobromide, a promising acetylcholinesterase inhibitor is reported to be
associated with cholinergic side effects. Its poor brain penetration results in lower bioavailability …

Artemisinin has been used effectively in malaria treatment. With the emerging resistance to
malaria, the optimum and judicial use of the drug has become important. The drug …

The 2019-novel coronavirus (nCoV) is a major source of disaster in the 21 th century. However,
the lack of specific drugs to prevent/treat an attack is a major need at this current point of …

A cerebrovascular accident, or stroke, is defined as the abrupt onset of a neurological deficit,
which can be due to ischemia. Cerebral ischemia is caused by a reduction in blood flow …

Following the demonstration of the efficacy of hydroxychloroquine against severe acute
respiratory syndrome coronavirus 2 in vitro, many trials started to evaluate its efficacy in clinical …

Alzheimer’s disease, a neurodegenerative disease with amyloid beta accumulation as a
major hallmark, has become a dire global health concern as there is a lack of clear …

Introduction COVID-19 cases are on surge; however, there is no efficient treatment or vaccine
that can be used for its management. Numerous clinical trials are being reviewed for use …

Over the past six decades, the drug resistance of Plasmodium falciparum has become an
issue of utmost concern. Despite the remarkable progress that has been made in recent years …